0001062993-19-002794.txt : 20190703
0001062993-19-002794.hdr.sgml : 20190703
20190703100233
ACCESSION NUMBER: 0001062993-19-002794
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190701
FILED AS OF DATE: 20190703
DATE AS OF CHANGE: 20190703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CALDWELL PATRICK M
CENTRAL INDEX KEY: 0001242121
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 19940296
MAIL ADDRESS:
STREET 1: C/O PROTINE DESIGN LAB
STREET 2: 532 BELLA CALAIS WAY
CITY: SAN JOSE
STATE: CA
ZIP: 94138
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2019-07-01
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001242121
CALDWELL PATRICK M
C/O BIOSPECIFICS TECHNOLOGIES CORP.
35 WILBUR STREET
LYNBROOK
NY
11563
0
1
0
0
Principal Financial Officer
Common Stock, $0.001 par value
2019-07-01
4
A
0
500
0
A
500
D
Grant of restricted stock units under the BioSpecifics Technologies Corp. 2019 Omnibus Incentive Compensation Plan.
/s/ Patrick M. Caldwell, by Carl A. Valenstein, attorney-in-fact
2019-07-03